ustekinumab
janssen
['ustekinumab', 'crohn']
(1/3) #ddw2023: today at 11 a.m. cdt, bri research assistant member james lord, md, phd, will be leading a presentation at in chicago titled ustekinumab decreases circulating th1, th17 and mait cells in #crohns disease. 
Benaroya Research Institute (BRI) is a world-renowned, nonprofit biomedical research institute focused on the immune system. Affiliated with @VMFHealth.